Patients Are Calling It Life Changing
The MonaLisa Touch™ is a new and exciting fractional laser created and manufactured for the purpose of resolving vaginal atrophy, a Genitourinary Syndrome of Menopause (GSM), which is a common condition associated with menopause and breast cancer survival.
“It offers a quick and painless remedy for a variety of medical conditions that prevent our patients from enjoying a healthy sex life,” says Dr. Jarad Fingerman, a physician at UCA Lawrenceville. “Traditional treatments are not an option for many women, so I’m grateful to be able to offer my patients this new alternative.”
The MonaLisa Touch, an in-office procedure that is virtually painless and requires no anesthesia, received FDA clearance in 2014. UCA Lawrenceville is among the first facilities in Central New Jersey to offer the gentle fractional CO2 laser. Procedures are performed at the UCA Lawrenceville office. Patients undergo three treatments spaced six weeks apart, and each treatment time is less than five minutes. Many women report symptom relief after the very first treatment, with even greater improvement after the third treatment.
“Patients in the studies experienced minimal (to no) side effects or adverse reactions and showed greater benefits with each treatment,” says Dr. Russell Freid, a physician also with UCA Lawrenceville. “With these kinds of outcomes, the MonaLisa Touch is a game-changing procedure for our menopausal patients.”
The MonaLisa Touch is a gentle laser therapy that delivers controlled energy to the vaginal wall tissue. It restores gynecologic health by generating new collagen, elastin and vascularization “The procedure enhances the blood flow and the nutrition to the vaginal tissue so it is more elastic and healthier,” explains Dr. Freid. “The laser revitalization stimulates collagen, similar to what is done with lasers on facial skin.”
For more information, or to schedule a consultation, please call the UCA Lawrenceville Office at 609-482-2220 or visit the UCA Lawrenceville Mona Lisa webpage.